IDX vs PNV

ASX Healthcare sector comparison — updated 22 Jul 2026 — Healthcare sector

IDX

INTEG DIAG FPO [IDX]

50MEDIUM

PNV

POLYNOVO FPO [PNV]

55MEDIUM

Score Breakdown

IDX PNV
Technical
51
41
Catalyst
53
57
Sentiment
50
50
Fundamental
100
90
Momentum
46
49
Risk Gate
34
35

Key Metrics

IDX Metric PNV
$776.0MMarket Cap$670.1M
681KAvg Volume (20d)1.5M
+1.4%Short Interest+8.8%
$3.07052-Week High$1.665
$1.90552-Week Low$0.865
-0.5%Daily Change-2.1%
$2.070Reference Price$0.950
+2.1%ROE+12.5%
+1.8%Profit Margin+7.1%

Active Signals

IDX Signals

●Beating the Small Ords index — relative strength of 1.10, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.0x)
●Strong revenue growth (+56%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (15% of range)
●New substantial holder(s) (1)

PNV Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 5.0% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.8x)
●Moderate revenue growth (+18%)
●Piotroski F-Score strong (8/9, low-confidence approx)

Ask Scout AI to compare IDX and PNV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IDX vs RCE →IDX vs RHY →IDX vs SNT →IDX vs TRP →IDX vs VIT →
IDX Full Analysis → PNV Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).